FH heterozygous mutations predispose to FH gene tumor susceptibility syndrome, characterized by cutaneous smooth muscle tumors, uterine smooth muscle tumors (leiomyosarcomas), or renal tumors. The gene discussed is FH; the disease is leiomyosarcoma.